Enzymatic assays for 2, 4-diamino-5-methyl-6-[(3, 4, 5-trimethoxyanilino)methyl]quinazoline, a promising new “nonclassical” antifolate
- 1 July 1981
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 70 (7) , 827-828
- https://doi.org/10.1002/jps.2600700737
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- INHIBITION OF HISTAMINE-METABOLIZING ENZYMES AND ELEVATION OF HISTAMINE LEVELS IN TISSUES BY LIPID-SOLUBLE ANTI-CANCER FOLATE ANTAGONISTS1980
- 2,4-Diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline (TMQ), a potent non-classical folate antagonist inhibitor—IBiochemical Pharmacology, 1979
- TOWARD IMPROVED SELECTIVITY IN CANCER CHEMOTHERAPY - RICHARD AND HINDA ROSENTHAL FOUNDATION AWARD LECTURE1979
- A Rapid Enzymatic Assay for Methotrexate in Serumcclm, 1979
- Methotrexate assay by enzymatic inhibition, with use of centrifugal analyzer.Clinical Chemistry, 1977
- 7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate.Journal of Clinical Investigation, 1976
- INHIBITOR BINDING ANALYSIS OF DIHYDROFOLATE REDUCTASES FROM VARIOUS SPECIES1965
- ENZYMATIC REDUCTION OF FOLIC ACID AND DIHYDROFOLIC ACID TO TETRAHYDROFOLIC ACIDJournal of Biological Chemistry, 1957